TriSalus Life Sciences (TLSI) Institutional Ownership $5.11 0.00 (0.00%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$5.24 +0.13 (+2.62%) As of 01/31/2025 06:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for TriSalus Life Sciences (NASDAQ:TLSI)CurrentInstitutional OwnershipPercentage2.58%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$2.78MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$388.40K Get TLSI Insider Trade Alerts Want to know when executives and insiders are buying or selling TriSalus Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TLSI Institutional Buying and Selling by Quarter TriSalus Life Sciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/20/2024Virtu Financial LLC19,875$92K0.0%N/A0.065% 11/16/2024Geode Capital Management LLC200,427$924K0.0%+45.4%0.657% 11/15/2024Vestcor Inc23,376$108K0.0%N/A0.077% 11/15/2024MSD Partners L.P.39,999$184K0.1%N/A0.131% 11/14/2024Walleye Capital LLC14,376$66K0.0%N/A0.047% 8/15/2024Duquesne Family Office LLC426,921$2.36M0.1%+35.1%1.572% 8/12/2024Highbridge Capital Management LLC214,545$1.18M0.0%N/A0.790% 8/2/2024Wolverine Asset Management LLC43,480$240K0.0%N/A0.160% 5/7/2024Anson Capital Inc.24,415$238K0.3%-30.3%0.091% 5/1/2024Connecticut Wealth Management LLC44,606$435K0.0%-22.0%0.167% 4/23/2024 Tyche Wealth Partners LLC10,000$98K0.0%-62.5%0.037% 1/30/2024 Tyche Wealth Partners LLC26,664$225K0.1%N/A0.101% 1/25/2024HC Advisors LLC101,736$860K0.5%N/A0.387% (Data available from 1/1/2016 forward) TLSI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TLSI shares? During the previous two years, 12 institutional investors and hedge funds held shares of TriSalus Life Sciences. The most heavily invested institutionals were Duquesne Family Office LLC ($2.36M), Highbridge Capital Management LLC ($1.18M), Geode Capital Management LLC ($924K), HC Advisors LLC ($860K), Connecticut Wealth Management LLC ($435K), Wolverine Asset Management LLC ($240K), and Anson Capital Inc. ($238K).Learn more on TLSI's institutional investors. What percentage of TriSalus Life Sciences stock is owned by institutional investors? 2.58% of TriSalus Life Sciences stock is owned by institutional investors. Learn more on TLSI's institutional investor holdings. Which institutional investors have been buying TriSalus Life Sciences stock? Of the 10 institutional investors that purchased TriSalus Life Sciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Highbridge Capital Management LLC ($214.55K), Duquesne Family Office LLC ($110.97K), HC Advisors LLC ($101.74K), Geode Capital Management LLC ($62.54K), Wolverine Asset Management LLC ($43.48K), MSD Partners L.P. ($40.00K), and Tyche Wealth Partners LLC ($26.66K). How much institutional buying is happening at TriSalus Life Sciences? Institutional investors have bought a total of 657,559 shares in the last 24 months. This purchase volume represents approximately $3.86M in transactions. Which TriSalus Life Sciences major shareholders have been selling company stock? The following institutional investors have sold TriSalus Life Sciences stock in the last 24 months: Tyche Wealth Partners LLC ($16.66K), Connecticut Wealth Management LLC ($12.58K), and Anson Capital Inc. ($10.59K). How much institutional selling is happening at TriSalus Life Sciences? Institutional investors have sold a total of 39,836 shares in the last 24 months. This volume of shares sold represents approximately $388.40K in transactions. Related Companies Semler Scientific Institutional Ownership Treace Medical Concepts Institutional Ownership Nano-X Imaging Institutional Ownership Delcath Systems Institutional Ownership CVRx Institutional Ownership Tactile Systems Technology Institutional Ownership ClearPoint Neuro Institutional Ownership ZimVie Institutional Ownership NeuroPace Institutional Ownership Electromed Institutional Ownership This page (NASDAQ:TLSI) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
